Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?

Author: Norum Jan   Holtmon Mari  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.44, Iss.7, 2005-10, pp. : 735-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content